<DOC>
	<DOC>NCT00542009</DOC>
	<brief_summary>Study of whether the investigational drug CE-326,597 improves glucose control and results in body weight loss in patients with type 2 diabetes</brief_summary>
	<brief_title>A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<criteria>Patients with type 2 diabetes, not on any or on oral (up to 2) antidiabetic medications, otherwise medically stable. Women of childbearing potential, people with unstable medical conditions, people with gallstones</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Phase 2A, safety and efficacy trial with CE-326,597 in patients with T2DM.</keyword>
</DOC>